Once free, drug for rare disease now being sold for $375K a year

https://www.nbcnews.com/nightly-new...-now-being-sold-for-375k-a-year-1439142467780

Thanks to a law designed to encourage drug development for rare diseases, Catalyst Pharmaceuticals can now sell the treatment exclusively for seven years -- and has set the price for it at $375,000 on average, when it used to be given to patients for free by a smaller drug company.
==================================================

https://www.biospace.com/article/be...maceuticals-over-price-of-lems-drug-firdapse/

Bernie Sanders Calls out Catalyst Pharmaceuticals Over Price of LEMS Drug Firdapse

U.S. Sen. Bernie Sanders has a history of taking on the pharmaceutical industry and prices for prescription medicines that he sees as unjust. This week, the Vermont senator has found a new target, Florida-based Catalyst Pharmaceuticals.

On Monday, Sanders sent a letter to Patrick J. McEnany, chairman and chief executive officer of Catalyst Pharmaceuticals, in regards to the $375,000 price tag for its recently-approved drug, Firdapse (amifampridine). In November 2018, after a previous rejection, Catalyst won approval from the U.S. Food and Drug Administration for the oral drug, as a first-ever approved treatment for Lambert-Eaton myasthenic syndrome (LEMS).
===================================================
How can Joe Downthestreet who has LEMS come up with $375K? This law on drugs for rare diseases should be looked at by regulators.